Latest News
Sanofi and Regeneron's Dupixent meets all endpoints in pivotal AFRS study; sBLA accepted for FDA priority review
7 November 2025 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) on Friday announced positive results from the phase 3 LIBERTY-AFRS-AIMS study evaluating Dupixent (dupilumab) in patients aged 6 years and older with allergic f...
Organon to sell JADA System to Laborie for up to USD465m
7 November 2025 - Healthcare company Organon (NYSE:OGN) announced on Friday that it has entered into an agreement to divest its JADA System to Laborie Medical Technologies Corp, a diagnostic and therapeutic medical technology company, for up to USD46...
Evinova China and Harbour BioMed form AI partnership to accelerate biologics development
7 November 2025 - Health-tech company Evinova and biopharmaceutical company Harbour BioMed (HKEX:02142) on Friday announced a strategic collaboration to apply artificial intelligence (AI) and digital technologies to drug discovery and development.The...
MavriX Bio reports first patient dosed in Phase 1/2 trial of MVX-220 for AS
7 November 2025 - Clinical-stage biotechnology company MavriX Bio and AS2Bio, a drug development accelerator established by the Foundation for Angelman Syndrome Therapeutics (FAST), announced on Thursday that the first patient has been dosed in the P...
OncoHost receives Proteomics Innovation of the Year in BioTech Breakthrough Awards
7 November 2025 - OncoHost, a technology company focused on transforming the approach to precision medicine for improved patient outcomes, announced on Thursday that it has received 'Proteomics Innovation of the Year' in the fifth annual Bi...